Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,330
Closed -$217K 4224
2025
Q4
$217K Sell
4,330
-653
-13% -$31.4K 0.01% 977
2025
Q3
$245K Buy
4,983
+174
+4% +$8.92K 0.01% 843
2025
Q2
$249K Sell
4,809
-559
-10% -$25.7K 0.02% 773
2025
Q1
$251K Buy
5,368
+1,465
+38% +$75.6K 0.02% 666
2024
Q4
$200K Buy
3,903
+149
+4% +$7.72K 0.02% 694
2024
Q3
$167K Buy
3,754
+229
+6% +$10K 0.02% 707
2024
Q2
$142K Buy
3,525
+530
+18% +$20.1K 0.02% 612
2024
Q1
$120K Buy
2,995
+548
+22% +$20.6K 0.02% 571
2023
Q4
$92.2K Buy
+2,447
New +$74.8K 0.03% 584

Other funds holding SNV

GAMMA Investing's SNV Position: Q1 2026 in Review

GAMMA Investing sold out of Synovus (SNV) in Q1 2026, closing a stake of 4,330 shares — an estimated $217K sold.

GAMMA Investing first reported a position in SNV in Q4 2023 and held it in 9 quarters. The position peaked at $251K in Q1 2025. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.

  • GAMMA Investing reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
  • GAMMA Investing sold 4,330 Synovus shares in Q1 2026, an estimated $217K.
  • GAMMA Investing first reported a position in Synovus in Q4 2023 and held it in 9 quarters.
  • GAMMA Investing's Synovus position peaked at $251K in Q1 2025.
  • 1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.

Based on GAMMA Investing's 13F filing for Q1 2026, filed 6 Apr 2026.